Christopher B. Fox

Seattle

Washington

Christopher B. Fox is the lead formulation engineer at the Infections Disease Research Institute

Articles

Characterization of Aluminum Hydroxide Gel and Oil-in-Water Emulsion Formulations Containing CpG ODNs

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).